10-K

Company

Immunovant, Inc.

Filed

June 8, 2022

Period of Report

March 31, 2022

Accession Number

0001764013-22-000059

A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →